Crescita Therapeutics Inc
TSX:CTX

Watchlist Manager
Crescita Therapeutics Inc Logo
Crescita Therapeutics Inc
TSX:CTX
Watchlist
Price: 0.45 CAD Market Closed
Market Cap: 8.4m CAD

Gross Margin
Crescita Therapeutics Inc

51.8%
Current
55%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
51.8%
=
Gross Profit
11.4m
/
Revenue
22.1m

Gross Margin Across Competitors

No Stocks Found

Crescita Therapeutics Inc
Glance View

Market Cap
8.4m CAD
Industry
Pharmaceuticals

Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. The company is headquartered in Mississauga, Ontario and currently employs 69 full-time employees. The company went IPO on 2016-03-07. The firm offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. The firm operates through three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products in both the Canadian and international markets. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis, MMPE and DuraPeel, on either an exclusive or non-exclusive basis. The Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization (CDMO) infrastructure, and sales of product development services.

CTX Intrinsic Value
0.6 CAD
Undervaluation 25%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
51.8%
=
Gross Profit
11.4m
/
Revenue
22.1m
What is the Gross Margin of Crescita Therapeutics Inc?

Based on Crescita Therapeutics Inc's most recent financial statements, the company has Gross Margin of 51.8%.

Back to Top